CI vs LPCN · P/E 2.4, rev $274.90B vs rev $11.2M
Cigna Corp (CI) versus Lipocine Inc (LPCN) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported LPCN revenue for 2024-12-31 was $11.2M. Net income was $8.4K. Revenue was up 492.8% from 2023-12-31 to 2024-12-31. LPCN currently screens at market cap $19.3M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. LPCN currently screens at market cap $19.3M.
Not investment advice. Open the CI and LPCN stock pages for the full models.
Not investment advice.